Spots Global Cancer Trial Database for ovary cancer
Every month we try and update this database with for ovary cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Mesenteric Infiltration in Ovarian Cancer | NCT06331130 | Ovary Cancer | Computed Tomogr... | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors | NCT02552121 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer... Esophagus Cance... Lung Cancer (NS... | Tisotumab vedot... | 18 Years - | Seagen Inc. | |
| MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer | NCT02582931 | Cancer of Ovary Cancer of the O... Neoplasms, Ovar... Ovarian Cancer Ovary Cancer Ovary Neoplasms | MRI-guided SBRT EORTC QLQ-C30 Q... EORTC QLQ-OV28 ... | 18 Years - | Washington University School of Medicine | |
| Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies | NCT00496860 | Progressive Met... | ALT-801 | 18 Years - | Altor BioScience | |
| Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy | NCT03593681 | Fallopian Tube ... Ovarian Cancer Ovarian Neoplas... Ovary Cancer Fallopian Tube ... Fallopian Tube ... High Grade Sero... Peritoneal Carc... Peritoneal Neop... Adnexal Mass Ovarian Disease... | Hysteroscopic c... | 18 Years - | Boston Scientific Corporation | |
| A Study of PF-07260437 in Advanced or Metastatic Solid Tumors | NCT05067972 | Ovarian Neoplas... Endometrial Neo... Breast Neoplasm... | PF-07260437 B7-H4 IHC | 18 Years - | Pfizer | |
| The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. | NCT03384511 | Malignancies Stomach Cancer Non-small Cell ... Esophageal Canc... Breast Cancer Ovary Cancer Cervical Cancer | Apatinib | 18 Years - | Shandong Cancer Hospital and Institute | |
| Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention | NCT05677048 | Gynecologic Can... Ovary Cancer Pancreatic Canc... Breast Cancer Lynch Syndrome Hereditary Brea... Colon Cancer Endometrial Can... Uterus Cancer | Free genetic te... IGNITE-TX Group IGNITE-TX and f... | 18 Years - | M.D. Anderson Cancer Center | |
| Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy | NCT06268665 | Breast Cancer Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... Invasive Breast... Ovarian Cancer Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Breast Cancer S... Breast Cancer I... Breast Cancer, ... Breast Cancer, ... Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... Cancer, Breast Tumors, Breast Mammary Cancer Mammary Carcino... Breast Carcinom... Breast Neoplasm Malignant Breas... Malignant Tumor... Cancer of Ovary Ovary Cancer Ovary Neoplasm | Tart Cherry Jui... | 18 Years - | University of California, Davis | |
| An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib | NCT05887609 | Ovary Cancer Peritoneal Canc... Fallopian Tube ... | Mirvetuximab So... Olaparib | 18 Years - 99 Years | University of Colorado, Denver | |
| The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer | NCT03162562 | Cancer of Ovary Neoplasms, Ovar... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovary Cancer | Oregovomab Poly ICLC | 18 Years - 90 Years | CanariaBio Inc. | |
| KORE-Innovation: a Prospective, Multi-site Clinical Trial to Implement and Analyse the Effects of an Innovative Perioperative Care Pathway to Reduce Complications for Patients With Ovarian Cancer | NCT05256576 | Ovary Cancer Fallopian Tube ... Peritoneum Canc... Frailty | Implementation ... | 18 Years - | Charite University, Berlin, Germany | |
| Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery | NCT02997553 | Breast Carcinom... Head and Neck C... Melanoma (Skin) Squamous Cell C... Cervix Cancer Endometrium Can... Ovary Cancer Vulva Cancer Anus Cancer Rectum Cancer | Indocyanine gre... Technetium99 Optonuclear pro... Quest Camera | 18 Years - | Institut de Cancérologie de Lorraine | |
| A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer | NCT05465590 | Advanced Solid ... Breast Cancer Non Small Cell ... Ovary Cancer Pancreatic Neop... | MB1707 | 18 Years - | Mainline Biosciences, Inc. | |
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors | NCT02001623 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer... Esophagus Cance... Lung Cancer(NSC... Squamous Cell C... | Tisotumab Vedot... | 18 Years - | Seagen Inc. | |
| SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours | NCT06329323 | Germ Cell Ovari... Germ Cell Tumor Germ Cell Cance... Germ Cell Neopl... Ovary Cancer Ovary Neoplasm Ovarian Cancer Ovarian Neoplas... | Blood test Pathology speci... | 16 Years - | Imperial College London | |
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors | NCT02001623 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer... Esophagus Cance... Lung Cancer(NSC... Squamous Cell C... | Tisotumab Vedot... | 18 Years - | Seagen Inc. | |
| Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer | NCT05080556 | Ovarian Cancer Relapsed Ovaria... Fallopian Tube ... Peritoneal Canc... Endometrioid Ca... High Grade Sero... Ovary Cancer | Carboplatin | 18 Years - | University College, London | |
| A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer | NCT05200364 | Ovarian Cancer Ovarian Carcino... Ovary Cancer Fallopian Tube ... Primary Periton... | STRO-002 Bevacizumab | 18 Years - | Sutro Biopharma, Inc. | |
| Olaparib Real-world Utilization and Clinical Outcomes in France, Italy, and the UK | NCT04532645 | Ovary Cancer | Olaparib | 18 Years - | AstraZeneca | |
| Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers | NCT03748186 | Ovarian Cancer Ovarian Carcino... Ovary Cancer Endometrial Can... Endometrioid Ad... Fallopian Tube ... Primary Periton... | STRO-002 | 18 Years - | Sutro Biopharma, Inc. | |
| ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors | NCT04205227 | Cancer Melanoma Ovary Cancer Pancreatic Canc... Solid Tumor | ENB003 Pembrolizumab | 18 Years - 80 Years | ENB Therapeutics, Inc | |
| Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers | NCT03748186 | Ovarian Cancer Ovarian Carcino... Ovary Cancer Endometrial Can... Endometrioid Ad... Fallopian Tube ... Primary Periton... | STRO-002 | 18 Years - | Sutro Biopharma, Inc. | |
| Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma | NCT00193297 | Ovary Cancer | Topotecan Paclitaxel Carboplatin | 18 Years - | SCRI Development Innovations, LLC | |
| Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer | NCT05059782 | Ovarian Cancer Neoplasm, Ovari... Ovarian Neoplas... Ovary Neoplasms Neoplasm, Ovary Neoplasms, Ovar... Ovary Neoplasm Neoplasms, Ovar... Ovary Cancer Cancer, Ovarian... Cancers, Ovary Ovary Cancers Cancer, Ovarian Cancers, Ovaria... Ovarian Cancers Cancer of Ovary Cancer of the O... | chemotherapy, t... IFRT, IMRT or S... | 18 Years - | Health Science Center of Xi'an Jiaotong University | |
| Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor | NCT02069158 | Breast Cancer NSCLC Ovary Cancer Endometrial Can... Small Cell Lung... Head and Neck (... | PF-05212384 Paclitaxel Carboplatin | 18 Years - | Oncology Institute of Southern Switzerland | |
| A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer | NCT05200364 | Ovarian Cancer Ovarian Carcino... Ovary Cancer Fallopian Tube ... Primary Periton... | STRO-002 Bevacizumab | 18 Years - | Sutro Biopharma, Inc. | |
| Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. | NCT03245736 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer Esophagus Cance... Lung Cancer, No... Squamous Cell C... | Tisotumab Vedot... | 18 Years - | Seagen Inc. | |
| Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker | NCT05763511 | Ovarian Neoplas... Ovary Cancer Ovarian Cysts | 18 Years - | University of Aarhus | ||
| Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker | NCT05763511 | Ovarian Neoplas... Ovary Cancer Ovarian Cysts | 18 Years - | University of Aarhus | ||
| Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) | NCT05403177 | Breast Cancer Colorectal Canc... Pancreas Cancer Kidney Cancer Prostate Cancer Ovary Cancer Head and Neck C... Leukemia Lymphoma Lung Cancer Melanoma Solid Tumor | 18 Years - | University Health Network, Toronto | ||
| Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health | NCT04000880 | Breast Cancer Colorectal Canc... Endometrial Can... Kidney Cancer Multiple Myelom... Ovary Cancer Prostate Cancer Thyroid Cancer Non-Hodgkin Lym... | Adapting MultiP... Diet-Exercise Exercise-Diet Combined Diet a... | 50 Years - | University of Alabama at Birmingham | |
| Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor | NCT02069158 | Breast Cancer NSCLC Ovary Cancer Endometrial Can... Small Cell Lung... Head and Neck (... | PF-05212384 Paclitaxel Carboplatin | 18 Years - | Oncology Institute of Southern Switzerland | |
| The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer | NCT03162562 | Cancer of Ovary Neoplasms, Ovar... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovary Cancer | Oregovomab Poly ICLC | 18 Years - 90 Years | CanariaBio Inc. | |
| Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines | NCT02432378 | Cancer of Ovary Cancer of the O... Neoplasms, Ovar... Ovarian Cancer Ovary Cancer Ovary Neoplasms | Cisplatin + cel... Cisplatin + CKM... | 18 Years - | Roswell Park Cancer Institute | |
| Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers | NCT05296564 | Sarcoma, Synovi... Sarcoma,Soft Ti... Melanoma Stage ... Triple Negative... Metastatic Canc... Non Small Cell ... Bladder Urothel... Neuroblastoma, ... Ovary Cancer | CYCLOPHOSPHAMID... Cyclophosphamid... HBI 0201-ESO TC... Aldesleukin | 18 Years - 70 Years | Hadassah Medical Organization | |
| Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. | NCT03245736 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer Esophagus Cance... Lung Cancer, No... Squamous Cell C... | Tisotumab Vedot... | 18 Years - | Seagen Inc. | |
| Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors | NCT05187338 | Lung Cancer Liver Cancer Colorectal Canc... Pancreas Cancer Ovary Cancer Head and Neck C... Breast Cancer Gastric Cancer Cervical Cancer Esophageal Canc... Sarcoma | ipilimumab +pem... | 18 Years - 70 Years | Second Affiliated Hospital of Guangzhou Medical University | |
| A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) | NCT05001282 | Ovarian Cancer Ovarian Neoplas... Ovarian Carcino... Endometrial Can... Ovary Cancer Ovary Neoplasm Ovary Disease Ovary Metastasi... Ovarian Disease... Ovarian Cancer ... Ovarian Epithel... Ovarian Adenoca... Ovarian Serous ... Ovarian Neoplas... Ovarian Cancer ... Endometrial Dis... Endometrial Ade... Endometrial Car... Endometrial Cle... Endometrioid Ad... Endometrial Neo... Endometrial Can... Endometrioid Tu... Fallopian Tube ... Peritoneal Canc... | ELU001 | 18 Years - | Elucida Oncology | |
| A Study of PF-07260437 in Advanced or Metastatic Solid Tumors | NCT05067972 | Ovarian Neoplas... Endometrial Neo... Breast Neoplasm... | PF-07260437 B7-H4 IHC | 18 Years - | Pfizer | |
| Effects of Music or Hypnotherapy on Cancer Patients During Chemotherapy | NCT03740984 | Breast Neoplasm Ovary Cancer | Interventions a... | 18 Years - | Dr. Horst Schmidt Klinik GmbH | |
| Rapamycin With Grapefruit Juice for Advanced Malignancies | NCT00375245 | Tumors Neoplasm Metast... | Rapamycin (siro... Grapefruit Juic... | 18 Years - | University of Chicago | |
| Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health | NCT04000880 | Breast Cancer Colorectal Canc... Endometrial Can... Kidney Cancer Multiple Myelom... Ovary Cancer Prostate Cancer Thyroid Cancer Non-Hodgkin Lym... | Adapting MultiP... Diet-Exercise Exercise-Diet Combined Diet a... | 50 Years - | University of Alabama at Birmingham | |
| Gynaecology Exercise and Mindfulness Study | NCT05561413 | Gynecologic Can... Uterus Cancer Ovary Cancer Cervical Cancer Vaginal Cancer Vulvar Cancer | Mindfulness and... Mindfulness | 18 Years - | University of Ulster | |
| The Effect of Glucose Level and Diabetes Mellitus on Ctrough of Olaparib | NCT05081765 | Ovary Cancer | Lynparza® (Astr... Lynparza | 18 Years - | Poznan University of Medical Sciences | |
| ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors | NCT04205227 | Cancer Melanoma Ovary Cancer Pancreatic Canc... Solid Tumor | ENB003 Pembrolizumab | 18 Years - 80 Years | ENB Therapeutics, Inc | |
| Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors | NCT05187338 | Lung Cancer Liver Cancer Colorectal Canc... Pancreas Cancer Ovary Cancer Head and Neck C... Breast Cancer Gastric Cancer Cervical Cancer Esophageal Canc... Sarcoma | ipilimumab +pem... | 18 Years - 70 Years | Second Affiliated Hospital of Guangzhou Medical University | |
| Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy | NCT03593681 | Fallopian Tube ... Ovarian Cancer Ovarian Neoplas... Ovary Cancer Fallopian Tube ... Fallopian Tube ... High Grade Sero... Peritoneal Carc... Peritoneal Neop... Adnexal Mass Ovarian Disease... | Hysteroscopic c... | 18 Years - | Boston Scientific Corporation | |
| Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy | NCT05990426 | Ovary Cancer Endometrial Can... Uterine Cancer | FAST Interventi... | 18 Years - | Northwestern University | |
| Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery | NCT02997553 | Breast Carcinom... Head and Neck C... Melanoma (Skin) Squamous Cell C... Cervix Cancer Endometrium Can... Ovary Cancer Vulva Cancer Anus Cancer Rectum Cancer | Indocyanine gre... Technetium99 Optonuclear pro... Quest Camera | 18 Years - | Institut de Cancérologie de Lorraine | |
| An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery | NCT03011320 | Ovary Cancer | EC1456 99mTc-Etarfolat... | 18 Years - | Endocyte |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
